PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 10, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PROCEPT BioRobotics Corporation ("PROCEPT" or "the Company") (NASDAQ:PRCT). Investors who purchased PROCEPT securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PRCT.

PROCEPT Investigation Details

On February 25, 2026, Procept reported fourth-quarter and full-year 2025 results, disclosing a larger-than-expected adjusted EBITDA loss and cutting its full-year 2026 revenue guidance to a range of $390 million to $410 million (down from its prior range of $410 million to $430 million). The Company attributed lower U.S. consumable revenue, in part, to eliminating its historical practice of providing discounts on bulk purchases to better align handpiece sales with procedure volumes. Following this news, Procept’s stock price dropped.

What’s Next for PROCEPT Investors?

If you are aware of any facts relating to this investigation or purchased PROCEPT securities, you can assist this investigation by visiting the firm’s site: bgandg.com/PRCT. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to PROCEPT Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for PROCEPT Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_475021065/2457/2026-03-10T18:03:23

Scroll to Top